CIK 0001005286
- Accelerated filer
- Smaller reporting company
LIFECORE BIOMEDICAL, INC. \DE\
Sign in to watch- Ticker
- LFCR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- May 25
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943025618
- Phone
- +1 952-368-4300
- Business address
- 3515 LYMAN BOULEVARD, CHASKA, MN, 55318
- Former names
- LANDEC CORP \CA\
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 8,303 shares (grant or award)
- 4 Grant or award Director acquired 8,303 shares (grant or award)
- 4 Grant or award Director acquired 8,303 shares (grant or award)
- 4 Grant or award Director acquired 8,303 shares (grant or award)
- 4 Grant or award Director acquired 8,303 shares (grant or award)
- 4 Grant or award Director acquired 8,303 shares (grant or award)
- 4 Grant or award Director acquired 8,303 shares (grant or award)
- 4 Open-market buy Director bought 10,000 shares at $11.26 ($112,600)
- 4 Open-market buy Senior VP of Supply Chain bought 5,045 shares at $9.99 ($50,400)
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at $11.05 ($22,100)
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at $11.08 ($22,160)
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at $10.98 ($21,960)
- 4 Open-market buy Chief Executive Officer bought 9,000 shares at $10.61 ($95,490)
- 4 Open-market buy Vice President bought 10,000 shares at $10.62 ($106,200)
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at $10.64 ($21,280)
- 4/A Open-market buy 10% owner bought 240,587 shares at an average $10.02 ($2,410,360)
Page 8 of 47 · 936 filings